# Beroe Inc.

Type: Company

Source: Supply Chain Intelligence Brief — https://getsupplybrief.com/entity/beroe-inc
Canonical HTML page: https://getsupplybrief.com/entity/beroe-inc

## Timeline

- **2029-08-01**: Tariff Escalates to 200% — The tariff rate doubles to 200% on generic drug imports.
- **2028-08-01**: 100% Tariff Takes Effect — A 100% duty is imposed on eligible generic drug imports.
- **2026-08-01**: Duty‑Free Period Begins — Imported generics enter a two‑year duty‑free window.
- **2026-07-21**: Generic Drug Tariff Schedule Announced — The President announces that generic drugs will remain duty‑free for two years, then face 100% (2028) and 200% (2029) tariffs under Section 232.
- **2026-04-02**: Executive Order Tariffs Patented Medicines — President Trump signs an order imposing 100% tariffs on imported patented drugs while exempting generics, biosimilars, and their ingredients.

## Recent coverage (1 stories)

### 100% Tariff on Generics to Squeeze Supply: 3-5 Year Reshoring Gap Leaves U.S. Vulnerable
2026-08-07 06:27:48 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

The impending 100% tariff on imported generic drugs could trigger widespread product discontinuations, as thin margins and pricing constraints block pass-through costs. With three to five years needed to build FDA-approved plants, supply chain disruptions are inevitable. The analysis explores manufacturing dependencies and risk exposure.
Full story: https://getsupplybrief.com/story/supply-chain-generic-drug-tariffs-reshoring-gap

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getsupplybrief.com/guides/methodology for the full editorial methodology.